A medical student delivers a COVID-19 booster shots at a pop up vaccine clinic in Ottawa, on Dec. 20, 2021.Justin Tang/The Canadian Press
Question: Will this fall’s COVID-19 vaccine booster shot protect me from the new variant EG.5 rapidly spreading across Canada?
Answer: The general consensus among medical experts is that EG.5 is closely related to the version of the virus targeted by the vaccine, so it should still work well.
It’s true that it’s challenging to create an effective COVID-19 booster shot. Work on an updated vaccine usually begins months before it is rolled out to the public. In the meantime, the virus continues to mutate and evolve, making it a moving target.
What you need to know is that COVID-19 vaccines train the immune system to recognize the spike protein, a knobby protrusion that the virus uses to invade cells. The vaccine essentially stimulates the production of antibodies that latch onto the spike protein and block the virus.
But as the virus mutates, the shape of the spike protein can change. That makes it more difficult for antibodies to do their job. As a result, COVID-19 vaccines need to be updated to deal with the latest version of the virus in circulation.
So how do manufacturers decide what to put into their vaccines?
The formulation of a vaccine involves “a collective decision-making process” that includes both government regulatory agencies as well as technical advisory groups from around the world, said Shehzad Iqbal, the Canadian medical director for Moderna, a leading manufacturer of COVID-19 vaccines.
Earlier this year, the World Health Organization recommended that the next vaccine should target an Omicron descendant lineage called XBB.1 or its close relatives. And then in June, a U.S. Food and Administration advisory committee endorsed XBB.1.5 as the target which, at the time, was the dominant form of the virus in the United States.
Now all the major COVID-19 vaccine manufacturers have made XBB.1.5′s spike protein their target.
It is worth noting that EG.5 is closely rated to XBB.1.5. “They are in the same family. EG.5 is actually a derivative of the XBB lineage,” said Angela Rasmussen, a virologist at the University of Saskatchewan.
“These two viruses are very, very similar from your immune system’s perspective. So there should be a good amount of protection from the XBB booster towards EG.5,” she added.
In fact, preliminary research for this fall’s vaccine supports that assumption.
Dr. Iqbal said that Moderna uses a “mouse-model system” to initially test the effectiveness of its vaccines against new variants. The mice are inoculated and then researchers carry out tests to see if the antibodies generated by the vaccine can block an infection.
The company also has a clinical trial program which follows people who have received COVID-19 vaccines. As part of this program, volunteers in the United States were given a booster shot that targets the XBB.1.5 variant. Blood samples, which contain the resulting antibodies, were collected for future studies.
“We have blood samples sitting in the freezer,” explained Dr. Iqbal. “So we pull out those samples and test them against new variants that come along.”
According to preliminary clinical trial data released last week by Moderna, the company’s vaccine generated “a significant boost in neutralizing antibodies against EG.5.”
In a telephone interview, Dr. Iqbal added that the vaccine produces a “very similar antibody response” to both XBB.1.5 and EG.5.
“This is giving us a degree of confidence that you are going to get a potentially protective response” from Moderna’s fall booster shot which is created using relatively new messenger-RNA vaccine technology, he said.
The other major manufacturer of messenger-RNA vaccines – Pfizer-BioNTech – did not respond to requests for an interview.
Experts are hoping that a successful booster shot program will help ease pressures on the health care system during the busy cold and flu season.
“Right now our thought is that the protection will be fairly good,” said Fahad Razak, an associate professor of medicine at the University of Toronto.
But, of course, there is always the possibility that a new variant could emerge in the coming months “and the vaccines are not going to be as effective against it,” noted Dr. Rasmussen.
Yet even if that happens, vaccines will likely be able to provide at least some degree of defense.
“We haven’t seen a situation where you get really good protection against one variant and zero protection against the next variant,” said Dr. Razak, who is also an internal medicine physician at St. Michael’s Hospital in Toronto.
“Rather, you get an eroding level of protection.”
That suggests the vaccines may not be able stop a new immune evading-variant from causing an infection. But they will likely still be able to prevent severe disease.
“We expect the vaccines will help keep people out of the hospital – and keep people out of the morgue,” said Dr. Rasmussen.
Paul Taylor is a former Patient Navigation Adviser at Sunnybrook Health Sciences Centre and former health editor of The Globe and Mail.
HALIFAX – The Nova Scotia government says it could be months before it reveals how many people are on the wait-list for a family doctor.
The head of the province’s health authority told reporters Wednesday that the government won’t release updated data until the 160,000 people who were on the wait-list in June are contacted to verify whether they still need primary care.
Karen Oldfield said Nova Scotia Health is working on validating the primary care wait-list data before posting new numbers, and that work may take a matter of months. The most recent public wait-list figures are from June 1, when 160,234 people, or about 16 per cent of the population, were on it.
“It’s going to take time to make 160,000 calls,” Oldfield said. “We are not talking weeks, we are talking months.”
The interim CEO and president of Nova Scotia Health said people on the list are being asked where they live, whether they still need a family doctor, and to give an update on their health.
A spokesperson with the province’s Health Department says the government and its health authority are “working hard” to turn the wait-list registry into a useful tool, adding that the data will be shared once it is validated.
Nova Scotia’s NDP are calling on Premier Tim Houston to immediately release statistics on how many people are looking for a family doctor. On Tuesday, the NDP introduced a bill that would require the health minister to make the number public every month.
“It is unacceptable for the list to be more than three months out of date,” NDP Leader Claudia Chender said Tuesday.
Chender said releasing this data regularly is vital so Nova Scotians can track the government’s progress on its main 2021 campaign promise: fixing health care.
The number of people in need of a family doctor has more than doubled between the 2021 summer election campaign and June 2024. Since September 2021 about 300 doctors have been added to the provincial health system, the Health Department said.
“We’ll know if Tim Houston is keeping his 2021 election promise to fix health care when Nova Scotians are attached to primary care,” Chender said.
This report by The Canadian Press was first published Sept. 11, 2024.
ST. JOHN’S, N.L. – Newfoundland and Labrador‘s chief medical officer is monitoring the rise of whooping cough infections across the province as cases of the highly contagious disease continue to grow across Canada.
Dr. Janice Fitzgerald says that so far this year, the province has recorded 230 confirmed cases of the vaccine-preventable respiratory tract infection, also known as pertussis.
Late last month, Quebec reported more than 11,000 cases during the same time period, while Ontario counted 470 cases, well above the five-year average of 98. In Quebec, the majority of patients are between the ages of 10 and 14.
Meanwhile, New Brunswick has declared a whooping cough outbreak across the province. A total of 141 cases were reported by last month, exceeding the five-year average of 34.
The disease can lead to severe complications among vulnerable populations including infants, who are at the highest risk of suffering from complications like pneumonia and seizures. Symptoms may start with a runny nose, mild fever and cough, then progress to severe coughing accompanied by a distinctive “whooping” sound during inhalation.
“The public, especially pregnant people and those in close contact with infants, are encouraged to be aware of symptoms related to pertussis and to ensure vaccinations are up to date,” Newfoundland and Labrador’s Health Department said in a statement.
Whooping cough can be treated with antibiotics, but vaccination is the most effective way to control the spread of the disease. As a result, the province has expanded immunization efforts this school year. While booster doses are already offered in Grade 9, the vaccine is now being offered to Grade 8 students as well.
Public health officials say whooping cough is a cyclical disease that increases every two to five or six years.
Meanwhile, New Brunswick’s acting chief medical officer of health expects the current case count to get worse before tapering off.
A rise in whooping cough cases has also been reported in the United States and elsewhere. The Pan American Health Organization issued an alert in July encouraging countries to ramp up their surveillance and vaccination coverage.
This report by The Canadian Press was first published Sept. 10, 2024.
All orders are protected by SSL encryption – the highest industry standard for online security from trusted vendors.
Bizarre Sunlight Loophole Melts Belly Fat Fast! is backed with a 60 Day No Questions Asked Money Back Guarantee. If within the first 60 days of receipt you are not satisfied with Wake Up Lean™, you can request a refund by sending an email to the address given inside the product and we will immediately refund your entire purchase price, with no questions asked.
:format(jpeg)/cloudfront-us-east-1.images.arcpublishing.com/tgam/TYS5WZ4OOVIC7B7SFOIR2AOTE4.jpg){kind=link}